Revenue
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
GeoVax Labs, Inc. (GOVX)
Price$0.4804Cached quote
Net income
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2009
2010
2011
2013
2014
2015
2017
2019
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.5M | $4.0M | $0 | $81,526 | $385,501 | $1.8M | $1.2M | $963,203 | $1.1M | $828,918 | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Research & development | $18.1M | $23.7M | $20.7M | $9.1M | $15.6M | $2.4M | $1.9M | $1.9M | $2.0M | $2.0M | $1.7M | $1.8M | $2.9M | $3.0M | $4.3M | $4.8M | $4.1M | — | — | — | — | — | — | — |
| Operating expenses | $24.1M | $29.1M | $26.7M | $14.1M | $19.1M | $4.6M | $3.5M | $3.5M | $3.2M | $4.1M | $3.1M | $3.6M | $4.7M | $4.8M | $7.2M | $8.0M | $7.0M | — | — | — | — | — | — | — |
| Operating income | −$21.6M | −$25.1M | −$26.7M | −$14.0M | −$18.7M | −$2.8M | −$2.4M | −$2.6M | −$2.2M | −$3.3M | −$2.7M | −$2.7M | −$2.3M | −$2.1M | −$2.3M | −$2.8M | −$3.3M | — | — | — | — | — | — | — |
| Operating margin | −869.34% | −635.83% | — | −17,207.47% | −4,862.72% | −154.46% | −201.76% | −266.06% | −202.22% | −394.90% | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| EBITDA | −$21.6M | −$25.0M | −$26.7M | −$14.0M | −$18.7M | −$2.8M | −$2.4M | −$2.5M | −$2.1M | −$3.2M | −$2.7M | −$2.7M | −$2.2M | −$2.0M | −$2.2M | −$2.7M | −$3.2M | — | — | — | — | — | — | — |
| EBITDA margin | −866.57% | −633.42% | — | −17,138.43% | −4,852.72% | −153.38% | −201.05% | −264.01% | −199.62% | −391.42% | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net income | −$21.5M | −$25.0M | −$26.0M | −$14.0M | −$18.6M | −$3.0M | −$2.4M | −$2.6M | −$2.2M | −$3.3M | −$2.7M | −$2.7M | −$2.3M | −$2.1M | −$2.3M | −$2.7M | −$3.3M | −$3.7M | −$4.2M | −$584,166 | −$1.6M | −$2.4M | −$947,804 | −$618,137 |
| Net profit margin | −862.34% | −631.98% | — | −17,198.35% | −4,817.19% | −162.21% | −201.60% | −265.79% | −201.82% | −394.70% | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Basic EPSper basic share | -$22.40 | -$120.46 | -$357.25 | -$309.75 | -$1,140.00 | -$802.50 | -$293.20 | -$150.00 | -$225.00 | -$600.00 | -$600.00 | -$750.00 | -$825.00 | -$900.00 | -$1,125.00 | -$1,350.00 | -$1,650.00 | — | — | — | — | — | — | — |
| Diluted EPSper diluted share | -$22.40 | -$120.46 | -$357.25 | -$311.25 | -$1,140.00 | -$802.50 | -$293.20 | -$150.00 | -$225.00 | -$600.00 | -$600.00 | -$750.00 | -$825.00 | -$900.00 | -$1,125.00 | -$1,350.00 | -$1,650.00 | — | — | — | — | — | — | — |
Owners
Reported shareholders
4.28%of listed shares
JANE STREET GROUP, LLC315.28K shares · Jun 30, 2026
View holders
| Holder | % owned |
|---|---|
JANE STREET GROUP, LLC | 4.28%315.28K shares |
HRT FINANCIAL LP | 1.72%126.7K shares |
DODD DAVID A | ≈0.50%36.66K shares |
SPENCER JOHN N JR | ≈0.29%21.4K shares |
GEODE CAPITAL MANAGEMENT, LLC | 0.29%21.11K shares |
Reynolds Mark | ≈0.19%14.01K shares |
TWO SIGMA SECURITIES, LLC | 0.14%10.68K shares |
Sharkey John W. | ≈0.08%6.19K shares |
VANGUARD FIDUCIARY TRUST CO | 0.07%5.07K shares |
Tower Research Capital LLC (TRC) | 0.05%3.5K shares |
McKee Kelly T. Jr. | ≈0.05%3.49K shares |
VANGUARD CAPITAL MANAGEMENT LLC | 0.04%3.22K shares |
SBI Securities Co., Ltd. | 0.04%2.59K shares |
MORGAN STANLEY | 0.03%2K shares |
JONES FINANCIAL COMPANIES LLLP | 0.01%1K shares |
UBS Group AG | 0.01%944 shares |
BlackRock, Inc. | 0.01%842 shares |
CITIGROUP INC | <0.01%230 shares |
WELLS FARGO & COMPANY/MN | <0.01%30 shares |
DANSKE BANK A/S | <0.01%3 shares |
Percentages use 7.37M shares of this listed class outstanding on Jun 30, 2026. ≈ compares the latest reported holding with a share total from a different date; it is not a confirmed current stake.
Gray completes the 100% scale. Reported positions may overlap; holders have different reporting dates.
Source: SEC Form 13F ↗Updated Sep 29, 2026 · Quarterly data
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Oct 17, 2025Form 4 | SPENCER JOHN N JRDirector | BuyCommon Stock | 10.0K | $0.55 | $5.5K | 21.4K |
| Aug 7, 2025Form 4 | McKee Kelly T. Jr.Chief Medical Officer | BuyCommon Stock | 1.1K | $0.67 | $741.69 | 3.5K |
| Apr 10, 2025Form 4 | SPENCER JOHN N JRDirector | BuyCommon Stock | 10.0K | $0.98 | $9.8K | 11.4K |
| Apr 10, 2025Form 4 | Sharkey John W.VP, Business Development | BuyCommon Stock | 6.0K | $0.99 | $5.9K | 6.2K |
| Apr 1, 2025Form 4 | DODD DAVID APresident, CEO | BuyCommon Stock | 10.0K | $1.08 | $10.8K | 36.7K |